Predictive role of blood urea nitrogen to serum albumin ratio (BAR) in all-cause mortality in patients with cirrhosis.
- 1Emergency Department, Civil Aviation General Hospital, Beijing, China.
Abstract
We aimed to assess the potential association between the blood urea nitrogen to serum albumin ratio (BAR) and all-cause mortality (ACM) in cirrhosis patients. We used X-tile software (V 3.6.1; Yale University, New Haven) to obtain the cutoff value and group the subjects. We applied 1:1 propensity score matching to reduce confounders. The primary endpoint events included ACM at 30, 90, and 365 days. The association between BAR and ACM was investigated using multivariable Cox regression analyses and Kaplan-Meier survival curves. After propensity score matching, we included 746 matched patient pairs based on a cutoff of 9.3. There were no significant differences in 30- and 90-day ACM rates between the 2 groups, while the 365-day ACM rates were 361 (48.4%) and 409 (54.8%; P = .013), respectively. Additionally, the multivariable Cox regression analysis showed that BAR was significantly associated with an increased risk of 365-day ACM, with a hazard ratio of 1.18 and a 95% confidence interval of 1.03 to 1.36; P = .022. The survival analysis showed that the low BAR group had a higher survival probability within 365 days (log-rank P = .046). BAR may be associated with 365-day mortality in hepatic cirrhosis patients in intensive care units.
Related
- Prognostic value of the blood urea nitrogen-to-albumin ratio for 28-day mortality in septic intensive care unit patients: a large-scale retrospective cohort study using the Medical Information Mart for Intensive Care IV database.
- Predictive value of the monocyte-to-albumin ratio at admission for 30-day mortality in elderly patients with spontaneous intracerebral hemorrhage: a retrospective analysis
- Plasma Cystatin C as a Marker of Acute-on-Chronic Liver Failure and 28-Day Mortality in Patients With Acutely Decompensated Liver Cirrhosis: A Prospective Observational Study
- The red blood cell distribution width-to-albumin ratio and 28-day mortality in patients with severe cardiogenic shock: a retrospective cohort study based on MIMIC-IV with single-center external validation
- Prognostic Value of the C-Reactive Protein-to-Albumin Ratio in Patients Hospitalized with Atrioventricular Block: Association with In-Hospital Mortality and Temporary Pacemaker Requirement
BibTeX
@article{zeng2026predictive,
title = {{Predictive role of blood urea nitrogen to serum albumin ratio (BAR) in all-cause mortality in patients with cirrhosis.}},
author = {ZhiCan Zeng and YaNan Liu and YaJing Dou and YaGuang Zhou},
journal = {Medicine},
year = {2026},
month = oct,
doi = {10.1097/md.0000000000051133},
url = {https://europepmc.org/article/MED/42888578},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Predictive role of blood urea nitrogen to serum albumin ratio (BAR) in all-cause mortality in patients with cirrhosis.
AU - ZhiCan Zeng
AU - YaNan Liu
AU - YaJing Dou
AU - YaGuang Zhou
PY - 2026
DA - 2026/10/01
JO - Medicine
DO - 10.1097/md.0000000000051133
UR - https://europepmc.org/article/MED/42888578
AB - We aimed to assess the potential association between the blood urea nitrogen to serum albumin ratio (BAR) and all-cause mortality (ACM) in cirrhosis patients. We used X-tile software (V 3.6.1; Yale University, New Haven) to obtain the cutoff value and group the subjects. We applied 1:1 propensity score matching to reduce confounders. The primary endpoint events included ACM at 30, 90, and 365 days. The association between BAR and ACM was investigated using multivariable Cox regression analyses and Kaplan-Meier survival curves. After propensity score matching, we included 746 matched patient pairs based on a cutoff of 9.3. There were no significant differences in 30- and 90-day ACM rates between the 2 groups, while the 365-day ACM rates were 361 (48.4%) and 409 (54.8%; P = .013), respectively. Additionally, the multivariable Cox regression analysis showed that BAR was significantly associated with an increased risk of 365-day ACM, with a hazard ratio of 1.18 and a 95% confidence interval of 1.03 to 1.36; P = .022. The survival analysis showed that the low BAR group had a higher survival probability within 365 days (log-rank P = .046). BAR may be associated with 365-day mortality in hepatic cirrhosis patients in intensive care units.
SN - 0304-5412
SN - 1536-5964
ER -